Procter & Gamble (PG) — Earnings Preview Memo
Key Points Table
| Factor | Details |
|---|---|
| Next Reported Period | Q4 FY2026 (quarter ending June 30, 2026) |
| Forward Consensus (Q4 FY26) | Revenue: $21,425M; Gross Margin: 48.3%; EBITDA: $5,073M; Net Income: $3,427M; EPS: $1.41 |
| Full-Year FY2026 Consensus | Revenue: $87,138M; Gross Margin: 50.6%; EBITDA: $23,819M; Net Income: $16,715M; EPS: $6.79 |
| Guidance (FY2026) | Organic Sales Growth: 0% to +4%; Net Sales Growth: +1% to +5%; Core EPS Growth: 0% to +4% ($6.83–$7.09); All-in EPS Growth: +1% to +6% ($6.51 base) |
| Guidance Commentary | Management expects FY26 EPS toward the lower end of range due to $150M after-tax commodity/logistics headwinds in Q4 and increased investments in innovation/demand creation. |
| Most Important Factors to Watch |
|
